Xtx Topco LTD Immunity Bio, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 105,883 shares of IBRX stock, worth $320,825. This represents 0.02% of its overall portfolio holdings.
Number of Shares
105,883
Previous 92,910
13.96%
Holding current value
$320,825
Previous $344,000
21.22%
% of portfolio
0.02%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding IBRX
# of Institutions
229Shares Held
82.3MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$52.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$34.6 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$29.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$12.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$11.6 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.21B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...